MedTrace Logo

Brain Network Activation and Gait and Posture in FXTAS

NCT02936531 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2021-03-17

No results posted yet for this study

Summary

In this study the investigators aim to identify and characterize a potential neurophysiological biomarker by mapping functional networks of brain activity (Brain Network Activation, BNA) based on analysis of evoked response potential (ERP) signals in both asymptomatic FMR1 premutation carriers and in patients with various stages of FXTAS. Additionally correlations will be studied between these BNA scores and demographics (gender, age and disease duration) as well as genetic mutation and clinical scores.

Conditions

  • Fragile X Associated Tremor-ataxia Syndrome
  • FXTAS

Sponsors & Collaborators

  • ElMindA Ltd

    collaborator INDUSTRY

  • Sheba Medical Center

    lead OTHER_GOV

Principal Investigators

  • Sharon Hassin, MD · Movement Disorders Instuitute, Sheba Medical Center

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-01
Primary Completion
2021-12-31
Completion
2022-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02936531 on ClinicalTrials.gov